Mangubat, Irene .
HRN: 24-12-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
CEFUROXIME 500MG (TAB)
11/22/2023
11/29/2023
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair; Thinly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes